Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Conditional replicating cytomegalovirus as a vaccine for CMV

Conditional replicating cytomegalovirus as a vaccine for CMV

US Patent 9546355 · Granted Jan 17, 2017

Estimated economic value: $176,841,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulations and processes for CAR T cell drug products2025
Herpes simplex virus vaccine2023
Methods of identifying schizophrenia patients at risk for relapse2023
HPV vaccine2023
Respiratory syncytial virus vaccine2022
CMV neutralizing antigen binding proteins2022
CMV neutralizing antigen binding proteins2022
HSV antigenic peptides and HSV protein vaccines2021
Cytomegalovirus surface protein complex for use in vaccines and as a drug target2021
Cytomegalovirus vaccines and methods of production2019
CMV neutralizing antigen binding proteins2018
CMV neutralizing antigen binding proteins2018